See also this year's filing and all EDGAR filings for this company.
PDF Report 0001133416_2023_GALECTIN_THERAPEUTICS_INC.pdf
Logs
Graph
Absolute values for 0001133416, GALECTIN THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 20,552,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 733,000 |
4 | LiabilitiesCurrent | 13,012,000 |
5 | LiabilitiesNoncurrent | 66,000 |
6 | remainder_Liabilities | 40,401,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 6,615,000 |
9 | ResearchAndDevelopmentExpense | 31,737,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -424,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 21,285,000 |
1 | Liabilities | 53,479,000 |
2 | Expenses | 38,352,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | -32,194,000 |
5 | NetIncome | -38,776,000 |
6 | ComprehensiveNetIncome | -38,776,000 |
7 | BaseVar | 56,770,000 |
8 | EconomicCapitalRatio | -2.52 |